Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.
Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page
- Check4 days agoChange DetectedThe study has expanded to include 81 locations and introduced new treatment arms involving cetuximab and divarasib, with some arms actively recruiting participants, while several previous details and locations have been removed.SummaryDifference26%
- Check12 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe website has added new features, while several menu items and links to external resources have been removed, streamlining the user interface.SummaryDifference4%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, introducing new features such as a menu for Participant Group/Arm and Intervention/Treatment, along with various download options and data fields.SummaryDifference4%
- Check55 days agoChange DetectedNew study dates have been added for 2024, 2027, and 2029, while multiple locations and contacts have been withdrawn from the study, indicating significant changes in participation and study status.SummaryDifference9%
Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.